There were 1,671 press releases posted in the last 24 hours and 442,845 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image